Utama › Kanser Paru-paru Sel Kecil
Kajian klinikal Kanser Paru-paru Sel Kecil sedang mengambil peserta di AS
98 kajian untuk Kanser Paru-paru Sel Kecil sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX26 kajian
- Arlington, VA23 kajian
- Boston, MA21 kajian
- New York City, NY21 kajian
- Nashville, TN20 kajian
- Los Angeles, CA20 kajian
- Orlando, FL15 kajian
- Dallas, TX13 kajian
- St. Louis, MO13 kajian
- Cleveland, OH13 kajian
- Detroit, MI12 kajian
- Chicago, IL12 kajian
- Washington, DC12 kajian
- Baltimore, MD11 kajian
- San Antonio, TX11 kajian
- Philadelphia, PA10 kajian
- Seattle, WA10 kajian
- Atlanta, GA9 kajian
- Durham, NC9 kajian
- Grand Rapids, MI9 kajian
- Tampa, FL9 kajian
- Edison, NJ9 kajian
- Queens, NY9 kajian
- Indianapolis, IN9 kajian
- Akron, OH8 kajian
- Aurora, CO8 kajian
- Columbus, OH8 kajian
- Cedar Rapids, IA8 kajian
- Miami, FL8 kajian
- Omaha, NE8 kajian
- Portland, OR8 kajian
- Austin, TX7 kajian
- New Haven, CT7 kajian
- Louisville, KY7 kajian
- Lexington, KY7 kajian
- Cincinnati, OH7 kajian
- West Valley City, UT7 kajian
- Clifton, NJ6 kajian
- Denver, CO6 kajian
- Irving, TX6 kajian
Mengikut negeri
- Alabama10 kajian
- Arizona9 kajian
- Arkansas5 kajian
- California36 kajian
- Colorado16 kajian
- Connecticut9 kajian
- Florida36 kajian
- Georgia12 kajian
- Illinois21 kajian
- Indiana12 kajian
- Iowa8 kajian
- Kansas3 kajian
- Kentucky15 kajian
- Maryland19 kajian
- Massachusetts22 kajian
- Michigan26 kajian
- Minnesota9 kajian
- Missouri17 kajian
- Nebraska10 kajian
- New Jersey17 kajian
- New Mexico3 kajian
- New York31 kajian
- North Carolina16 kajian
- Ohio28 kajian
- Oklahoma4 kajian
- Oregon9 kajian
- Pennsylvania15 kajian
- South Carolina7 kajian
- South Dakota3 kajian
- Tennessee24 kajian
- Texas41 kajian
- Utah11 kajian
- Virginia30 kajian
- Washington13 kajian
- Wilayah Columbia5 kajian
- Wisconsin11 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07155174Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT02146170Prospective Multiomic Analysis in Small-Cell Lung Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07795411Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07509034The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03460977A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07472517Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07476287Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07226999A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07099898DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Mengambil pesertaFasa 1
Umur 18 hingga 100 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07006727Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07488676A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06066138Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432Study of Trilaciclib and Lurbinectidin
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05578326A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07730021A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07459634A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07407933Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.